UNSPSC 51283725: Cefuroxime pivoxetil

This classification denotes a cephalosporin antibiotic C23H28N4O11S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LR90117565, chemically known as 1-hydroxyethyl (6r,7r)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7^2-(z)-(o-methyloxime), 3-carbamate 1-(2-methoxy-2-methylpropionate), but more generally known as cefuroxime pivoxetil, which bears US NIH Compound Identifier 9595289.

Most nations, for tariff and trade purposes, schedule cefuroxime pivoxetil under HS 29419000 and SITC 54139. As of Q4 2014, CEFUROXIME PIVOXETIL remains US FDA's Preferred Term for this commodity. Cefuroxime pivoxetil bears US NLM identifiers UMLS ID C2699152 and NCI Concept Code C76178. SMILES: CC(OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3CCCO3)COC(=O)N)OC(=O)C(C)(C)OC.

UNSPSC 51283725 Cefuroxime pivoxetil, a Commodity code, shows no recent state and local procurement activity aligned with its scope. The two opportunities tagged under this code — an Illinois Department of Public Health pharmaceutical warehouse piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (completed award to Chartwell Rx LLC, August 28, 2026) and a Seminole County, Florida IFB for Naloxone and drug deactivation systems (due July 26, 2023) — neither involves cefuroxime pivoxetil procurement. The pharmaceutical products and medical supplies listed fall outside the antibiotic class this code nominates, indicating either miscoding in state and local procurement systems or that the code has not generated genuine cefuroxime pivoxetil solicitations at the state and local level in the recent window. Buyers pursuing this commodity should monitor health department and correctional facility RFQs and cooperative purchasing vehicles that commonly handle generic pharmaceuticals, but should not rely on this code as a reliable signal for current market activity.